Search results
Find the latest Jazz Pharmaceuticals plc (JAZZ) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
See Jazz Pharmaceuticals plc (JAZZ) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Investor Contacts. Andrea N. Flynn, Ph.D. Vice President, Head, Investor Relations. investorinfo@jazzpharma.com Ireland: +353 1 634 3211 U.S.: +1 650 496 2717
5 days ago · Jazz Pharmaceuticals stock has received a consensus rating of buy. The average rating score is and is based on 42 buy ratings, 7 hold ratings, and 0 sell ratings. What was the 52-week low for Jazz ...
May 22, 2024 · A high-level overview of Jazz Pharmaceuticals plc (JAZZ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Feb 28, 2024 · JAZZ. Total Revenues: $3.8 billion in 2023, with a 27% year-over-year increase from key growth drivers. Oncology Revenue: Surpassed $1 billion in 2023, marking a significant milestone. GAAP Net ...
1 day ago · Jazz Pharmaceuticals (NASDAQ:JAZZ) Insider Buying and Selling Activity. Current Insider Ownership Percentage. 4.40%. Number Of Insiders Buying (Last 12 Months) 1. Amount Of Insider Buying (Last 12 Months) $1.44 M. Number Of Insiders Selling (Last 12 Months) 4.
